팜스코 036580

http://comp.fnguide.com/SVO2/asp/SVD_Main.asp?pGB=1&gicode=A036580&cID=&MenuYn=Y&ReportGB=&NewMenuID=101&stkGb=701 

팜스코(A036580) | Snapshot | 기업정보 | Company Guide

- 4Q18 실적 부진보다 2019년 영업환경 개선에 주목 - KB증권 - 2019.01.25 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=510378
- 사료 중심의 실적 개선이 4Q에 나타날 전망 Buy 유지 목표주가 (하향, 원) 11,000 
  Upside / Downside (%) 40.1 현재가  (11/13, 원) 7,850 - KB증권 - 2018.11.14 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=501739
- 외부 변수에 민감한 점 고려해도 저평가 Buy 유지 목표주가 (하향, 원) 13,000
  Upside / Downside (%) 30.3 현재가 (9/6, 원) 9,980 - KB증권 - 2018.09.07 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=492504
- 2017년 영업환경 악화 고려 시 선방한 실적 Buy 유지 목표주가 (상향, 원) 16,500 
  Upside / Downside (%) 21.8 현재가 (1/23, 원) 13,550 - KB증권 - 2018.01.24 
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=461423 
- 사료 판매량 회복과 점유율 확대에 주력한 결과 Buy 유지 목표주가 (유지, 원) 15,000 -
  KB증권 - 2017.11.14
  http://hkconsensus.hankyung.com/apps.analysis/analysis.downpdf?report_idx=452077

-  1Q 영업이익 43.1% 증가, KB증권 추정치 상회 
-  2013년부터 나타난 실적 향상이 2017년에도 지속될 전망  
   장기 성장성과 저평가매력도 부각, 투자의견 BUY 유지"  - 
   KB증권 - 2017.05.12 -  KB20170512팜스코.pdf